These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10698508)

  • 21. p53 is involved in the p120E4F-mediated growth arrest.
    Sandy P; Gostissa M; Fogal V; Cecco LD; Szalay K; Rooney RJ; Schneider C; Del Sal G
    Oncogene; 2000 Jan; 19(2):188-99. PubMed ID: 10644996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin.
    Jaks V; Jõers A; Kristjuhan A; Maimets T
    Oncogene; 2001 Mar; 20(10):1212-9. PubMed ID: 11313865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells.
    Saleh-Gohari N; Helleday T
    Nucleic Acids Res; 2004; 32(12):3683-8. PubMed ID: 15252152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High and low fluences of alpha-particles induce a G1 checkpoint in human diploid fibroblasts.
    Azzam EI; de Toledo SM; Waker AJ; Little JB
    Cancer Res; 2000 May; 60(10):2623-31. PubMed ID: 10825133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis.
    Sigal A; Matas D; Almog N; Goldfinger N; Rotter V
    Oncogene; 2001 Aug; 20(35):4891-8. PubMed ID: 11521201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 Protein interacts specifically with the meiosis-specific mammalian RecA-like protein DMC1 in meiosis.
    Habu T; Wakabayashi N; Yoshida K; Yomogida K; Nishimune Y; Morita T
    Carcinogenesis; 2004 Jun; 25(6):889-93. PubMed ID: 14764457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of multicopy suppressors of cell cycle arrest at the G1-S transition in Saccharomyces cerevisiae.
    Muñoz I; Simón E; Casals N; Clotet J; Ariño J
    Yeast; 2003 Jan; 20(2):157-69. PubMed ID: 12518319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P53-mediated G(1)/S checkpoint dysfunction in lymphocytes from Alzheimer's disease patients.
    Zhou X; Jia J
    Neurosci Lett; 2010 Jan; 468(3):320-5. PubMed ID: 19914341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 in recombination and repair.
    Gatz SA; Wiesmüller L
    Cell Death Differ; 2006 Jun; 13(6):1003-16. PubMed ID: 16543940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53-dependent change in replication timing of the human genome.
    Watanabe Y; Shibata K; Sugimura H; Maekawa M
    Biochem Biophys Res Commun; 2007 Dec; 364(2):289-93. PubMed ID: 17949684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
    Honma M
    Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle regulation and the p53 tumor suppressor protein.
    Mercer WE
    Crit Rev Eukaryot Gene Expr; 1992; 2(3):251-63. PubMed ID: 1511188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.
    Tarapore P; Tokuyama Y; Horn HF; Fukasawa K
    Oncogene; 2001 Oct; 20(47):6851-63. PubMed ID: 11687964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control.
    Pollock R; Lang A; Ge T; Sun D; Tan M; Yu D
    Clin Cancer Res; 1998 Aug; 4(8):1985-94. PubMed ID: 9717829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of inactivating various components of the signal pathways of the tumor suppressor p53 on genomic stability].
    Turovets NA; Chumakov PM; Kopnin BP
    Genetika; 1999 Dec; 35(12):1651-8. PubMed ID: 10687094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat-induced G1 arrest is dependent on p53 function but not on RB dephosphorylation.
    Miyakoda M; Nakahata K; Suzuki K; Kodama S; Watanabe M
    Biochem Biophys Res Commun; 1999 Dec; 266(2):377-81. PubMed ID: 10600511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic instability and the role of p53 mutations in cancer cells.
    Smith ML; Fornace AJ
    Curr Opin Oncol; 1995 Jan; 7(1):69-75. PubMed ID: 7696366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53's double life: transactivation-independent repression of homologous recombination.
    Bertrand P; Saintigny Y; Lopez BS
    Trends Genet; 2004 Jun; 20(6):235-43. PubMed ID: 15145576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.